00
Pennsylvania health officials reported a fifth measles-associated death and 943 total cases as the state faces its worst outbreak in over 35 years. The unvaccinated person died in Lancaster County amid the nation's largest ongoing measles outbreak.
Gene-editing company Beam Therapeutics filed lawsuits against YolTech Therapeutics, Serapha Bio, and two Chinese scientists, alleging a former Beam scientist stole confidential base editing technology and trade secrets to develop a competing rare disease therapy.
Researchers at the University of Pittsburgh published a study in PNAS demonstrating an experimental mRNA therapy that dramatically extends the treatment window for acetaminophen overdose-related liver injury in preclinical models. The current FDA-approved antidote, N-acetylcysteine, must be administered within hours to be effective.
Unite Us and Instacart announced a partnership to connect healthcare organizations' care coordination efforts with grocery benefits, aiming to make food-as-medicine programs easier to launch and operate at scale. The collaboration integrates Unite Us's community-based care coordination technology with Instacart's grocery delivery platform.
Merck and Daiichi Sankyo ended plans to seek accelerated FDA approval for their antibody-drug conjugate I-DXd in lung cancer after the agency indicated existing data wouldn't support the pathway, erasing a competitive advantage over rivals.
The CDC's Annual Report to the Nation on the Status of Cancer shows breast and prostate cancer incidence is increasing among all racial and ethnic groups in the U.S., while lung cancer incidence and mortality rates are declining sharply.
The FDA has approved Roche's obinutuzumab (Gazyva), an anti-CD20 agent, for treating idiopathic nephrotic syndrome in patients as young as 2 years old. This marks the first new drug approval for this kidney condition in seven decades.
The FDA has approved Juvmo (tavapadon), the first and only dopamine agonist designed to selectively target D1/D5 receptors for treating adults with Parkinson's disease. The once-daily oral tablet can be taken with or without levodopa therapy and came from AbbVie's $8.7 billion acquisition of Cerevel Therapeutics.
East Suffolk and North Essex NHS Foundation Trust has removed or suspended ten staff members following unauthorized access to the digital medical records of three-year-old Noah Woods, who was found dead in a pond in Brantham, Suffolk. The trust has launched an urgent investigation and apologized for the breach, calling any unauthorized access of patient data "completely unacceptable."
UnitedHealthcare and TeamHealth have settled a lawsuit in which the insurer accused the physician staffing company of upcoding emergency department claims. The case was voluntarily dismissed with prejudice on September 24 in Tennessee federal court.
All of the news data is pulled from the Health space in Geo
All of the news data is pulled from the Health space in Geo